HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Japanese Encephalitis Vaccines

Vaccines or candidate vaccines used to prevent infection with Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE).
Also Known As:
Encephalitis Vaccine, Japanese; Encephalitis Vaccines, Japanese; Vaccine, Japanese Encephalitis; Vaccines, Japanese Encephalitis; Japanese Encephalitis Vaccine
Networked: 78 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kurane, Ichiro: 3 articles (10/2016 - 11/2003)
2. Takasaki, Tomohiko: 3 articles (10/2016 - 11/2003)
3. Liu, Xiaoyu: 2 articles (06/2022 - 12/2021)
4. Wang, Ruize: 2 articles (06/2022 - 12/2021)
5. Zhang, Chao: 2 articles (06/2022 - 12/2021)
6. Zhang, Shaobai: 2 articles (06/2022 - 12/2021)
7. Chinese Preventive Medicine Association: 2 articles (02/2021 - 02/2021)
8. Endy, Timothy P: 2 articles (01/2020 - 09/2013)
9. Marfin, Anthony A: 2 articles (01/2020 - 03/2005)
10. Thomas, Stephen J: 2 articles (01/2020 - 09/2013)

Related Diseases

1. Poliomyelitis (Polio)
2. Diphtheria
3. Dengue (Dengue Fever)
4. Encephalitis (Encephalitis, Rasmussen)
5. Tetanus
01/01/2023 - "The most concerned vaccines were diphtheria, tetanus and acellular pertussis combined vaccine, diphtheria and tetanus combined vaccine, meningococcal polysaccharide vaccine and Japanese encephalitis vaccine. "
01/01/2014 - "Specific discussion areas included the development of WHO guidance on the quality, safety and efficacy of poliomyelitis vaccines; recombinant malaria vaccines; diphtheria vaccines; tetanus vaccines; combined vaccines based on diphtheria and tetanus vaccines; and Japanese encephalitis vaccines. "
01/02/2017 - "The coverage rate of bacillus calmette-guerin (BCG), hepatitis B vaccine 1st to 3rd doses (HepB1-3), oral poliovaccine 1st dose (OPV1), diphtheria, pertussis and tetanus 1st dose (DPT1), DPT1-3, meningococcal polysaccharide vaccine group A (MPVA), measles amd rubella vaccine/measles vaccine 1st dose (MRV/MCV1), and Japanese encephalitis vaccine 1st dose (JEV1) were 100%(72 cases), 75%(51 cases), 97%(66 cases), 91%(62 cases), 82%(56 cases), 66%(45 cases), 69%(42 cases), and 61%(37 cases) respectively. "
01/01/2020 - "We performed a systematic review of all published literature concerning the safety of vaccines frequently given to travellers such as yellow fever, MMR (mumps, measles and rubella), influenza, Tdap (tetanus, diphtheria and pertussis), meningococcus, hepatitis A and B, rabies, polio, typhoid fever, tick-borne encephalitis and Japanese encephalitis vaccines. "
04/02/2020 - "The vaccination coverage rates of Bacillus Calmette-Guerin (BCG) vaccine, the 3(rd) dose of hepatitis B, the 3(rd) dose of polio, the 3(rd) dose of diphtheria-pertussis-tetanus, the 1(st) dose of meningococcal polysaccharide group A, the 1(st) dose of measles or measles and rubella vaccine, the 1(st) dose of Japanese encephalitis vaccine, hepatitis A, measles-mumps-rubella, and group A+C meningococcal polysaccharide vaccine were 100.0% (192 cases), 94.3% (181 cases), 81.8% (157 cases), 88.5% (170 cases), 83.9% (161 cases), 76.6% (147 cases), 80.2% (154 cases), 68.2% (131 cases), 69.8% (134 cases), 54.7% (105 cases), respectively. "

Related Drugs and Biologics

1. Vaccines
2. Neutralizing Antibodies
3. Combined Vaccines
4. Malaria Vaccines
5. Synthetic Vaccines (Recombinant Vaccines)
6. delta inulin
7. Immunoglobulin M (IgM)
8. Dengue Vaccines
9. Measles-Mumps-Rubella Vaccine (MMR Vaccine)
10. Immunoglobulin A (IgA)

Related Therapies and Procedures

1. Transplantation